Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Seventh Generation Bonding Agents as Short-Term Desensitizers Among Patients With Hypersensitivity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy males or females of 18 to 45 years of age~* Hypersensitive teeth to air and tactile stimultaion~* Gingival recession of Miller Class I and II~* Score 1 of Silness and Loe Plaque index~* Participants who have no sysytemic illness~* Patients who agree to give consent were included in the study.~Exclusion Criteria:~* Carious teeth~* Fractured restoration or cracked teeth~* Teeth undergoing orthodontic or periodontal treatment at sensitive site~* Patients who had dental bleaching in last 03 months~* Patients taking pain killers~* Smokers~* Pregnant and nursing females were excluded from the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Group-I Single Bond Universal (Type: ACTIVE_COMPARATOR): it is a seventh generation bonding agent used as desensitizer, manufactured by 3M ESPE.~applied on the affected surface of the group-I participants.
- Group-II Xeno V+ (Type: ACTIVE_COMPARATOR): it is a seventh generation bonding agent used as desensitizer, manufactured by Dentsply.~applied on the affected surface of the group-II participants.
- Group-III Bifluorid 12 (Type: PLACEBO_COMPARATOR): it is a fluoride varnish used as desensitizer, manufactured by VOCO. applied on the affected surface of the group-III participants.

Based on this trial design, predict the completion outcome and termination type (if applicable).